Medication error during Alliana nurses' strike changed hospital’s CMS status

CMS placed Abbott Northwestern Hospital in Minneapolis on “immediate jeopardy” status after a replacement nurse was involved in a medication error during a recent nursing strike.

According to the Minneapolis Star-Tribune, the nurse severely injured asthmatic patient Joyce Tagba on Sept. 17 by contradicting doctor’s order by administering adrenaline through an IV instead of into the muscle. The error caused an irregular, rapid heartbeat in Tagba, who lost consciousness and was placed in intensive care for three days. She is reportedly progressing with physical therapy to regain the feeling she lost.

“That just never should have happened. I suspect it was due to people who were not used to working with one another” during the strike, Gary Manka, Togba’s attorney, told the Star-Tribune.

The hospital self-reported the error and CMS accepted the corrective actions of placing a nursing observer in the emergency department when needed and retraining nurses to repeat back verbal orders.

The strike at Abbott and four other Alliana hospitals lasted a week in June and then from Sept. 5 to Oct. 16, during which time replacement nurses were brought in to keep the hospitals in operation. Alliana CMO Timothy Sielaff, MD, said the incident couldn’t be blamed solely on the replacement nurse, characterizing it as a communication breakdown.

For more on communication problems during the nurses’ strike, click on the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.